Search Results for: CCL21

Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel CCL27 C-C motif chemokine ligand 27
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
Novel DCTN3 dynactin subunit 3
  • MHC class II antigen presentation
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • COPI-mediated anterograde transport
  • COPI-independent Golgi-to-ER retrograde traffic
  • AURKA Activation by TPX2
Novel GALT galactose-1-phosphate uridylyltransferase
  • Defective GALT can cause GALCT
  • Galactose catabolism
  • Galactosemia
Novel IL11RA interleukin 11 receptor subunit alpha
  • IL-6-type cytokine receptor ligand interactions
  • Oprelvekin
Novel RNF38 ring finger protein 38
ACKR2 atypical chemokine receptor 2
  • Chemokine receptors bind chemokines
ACKR4 atypical chemokine receptor 4
  • Chemokine receptors bind chemokines
C3orf52 chromosome 3 open reading frame 52
CCL13 C-C motif chemokine ligand 13
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
CCL17 C-C motif chemokine ligand 17
  • Chemokine receptors bind chemokines
CCL23 C-C motif chemokine ligand 23
CCL24 C-C motif chemokine ligand 24
CCL26 C-C motif chemokine ligand 26
CCL28 C-C motif chemokine ligand 28
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
CCL5 C-C motif chemokine ligand 5
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Interleukin-10 signaling
  • Heparin Disaccharide I-S
  • Heparin Disaccharide Iii-S
CCR7 C-C motif chemokine receptor 7
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
CTSD cathepsin D
  • Collagen degradation
  • Metabolism of Angiotensinogen to Angiotensins
  • MHC class II antigen presentation
  • Neutrophil degranulation
  • Insulin receptor recycling
  • Estrogen-dependent gene expression
  • S-Methylcysteine
  • 1h-Benoximidazole-2-Carboxylic Acid
  • 2-Morpholinoethylamine
  • 5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid
  • CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE
  • Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
  • Neuronal ceroid lipofuscinosis, including: Infantile Neuronal Ceroid Lipofuscinosis (INCL)/ Santavuori-Haltia Disease (CLN1); Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL)/ Jansky-Bielschowsky Disease (CLN2); Juvenile Neuronal Ceroid Lipofuscinosis (JNCL)/Batten Disease/ Spielmeyer-Vogt Disease (CLN3); Adult Neuronal Ceroid Lipofuscinosis (ANCL)/ Kufs Disease (CLN4); LINCL variant (CLN5, CLN6, CLN7, CLN8); Batten Disease variant (CLN9); Congenital NCL (CLN10)
CXCL10 C-X-C motif chemokine ligand 10
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Interleukin-10 signaling
  • N-Methylleucine
  • Eldelumab
  • Clove oil
CXCL11 C-X-C motif chemokine ligand 11
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
CXCL12 C-X-C motif chemokine ligand 12
  • Nuclear signaling by ERBB4
  • Signaling by ROBO receptors
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
  • Estrogen-dependent gene expression
  • CTCE-0214
  • Tinzaparin

Page 1 out of 2 pages